Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated CLL/SLL: Updated results from the phase 1/2 BRUIN study Meeting Abstract
| Authors: | Mato, A.; Pagel, J.; Coombs, C.; Shah, N.; Lamanna, N.; Munir, T.; Lech-Maranda, E.; Eyre, T.; Woyach, J.; Wierda, W.; Cheah, C.; Cohen, J.; Roeker, L.; Patel, M.; Fakhri, B.; Barve, M.; Tam, C.; Lewis, D.; Gerson, J.; Alencar, A.; Ujjani, C.; Flinn, I.; Sundaram, S.; Ma, S.; Jagadeesh, D.; Rhodes, J.; Taylor, J.; Abdel-Wahab, O.; Ghia, P.; Schuster, S.; Wang, D.; Nair, B.; Zhu, E.; Tsai, D.; Davids, M.; Brown, J.; Jurczak, W. |
| Abstract Title: | Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated CLL/SLL: Updated results from the phase 1/2 BRUIN study |
| Meeting Title: | 62nd Annual Scientific Meeting of the British Society for Haematology |
| Journal Title: | British Journal of Haematology |
| Volume: | 197 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Apr 3-5 |
| Meeting Location: | Manchester, United Kingdom |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2022-04-01 |
| Start Page: | 97 |
| End Page: | 101 |
| Language: | English |
| ACCESSION: | WOS:000776484300105 |
| PROVIDER: | wos |
| PUBMED: | 35362090 |
| DOI: | 10.1111/bjh.18134 |
| Notes: | Meeting Abstract: BSH22-PO55 -- Hybrid meeting, also held virtually -- Source: Wos |
